Insider · CIK 0001908860
Scott G. Davis
Files at CHRN (EKSO BIONICS HOLDINGS, INC.). First filing Nov 12, 2025, latest Nov 12, 2025.
In brief
Scott G. Davis files SEC Form 4 as CEO and director at CHRN (EKSO BIONICS HOLDINGS, INC.). Since Nov 12, 2025, Scott G. Davis has reported 0 open-market buys worth $0 and 1 open-market sell worth $112k, the latest filed on Nov 12, 2025.
A track record needs three past buys with six months of prices behind them; Scott G. Davis has 0, so none is measured yet.
The newest scored trade: sold $112k of CHRN on Nov 10, 2025, filed Nov 12, 2025, scored 55 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $112k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CHRN: EKSO BIONICS HOLDINGS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 55Moderate | EKSO BIONICS HOLDINGS, INC. | $112k 23,315 shares | -23% | - |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | CHRN EKSO BIONICS HOLDINGS, INC. | AGrant or award Common Stock | +51,626 | $0.00 | $0 | 239,760 | 8 d ago |
| May 14, 2026 | CHRN EKSO BIONICS HOLDINGS, INC. | AGrant or award Common Stock | +109,357 | $0.00 | $0 | 188,134 | May 18, 2026 |
| Nov 10, 2025 | CHRN EKSO BIONICS HOLDINGS, INC. | SOpen-market sale Common Stock | -23,315 | $4.80 | $112k | 78,777 | Nov 12, 2025 |
| Nov 5, 2025 | CHRN EKSO BIONICS HOLDINGS, INC. | AGrant or award Common Stock | +80,000 | $0.00 | $0 | 102,092 | Nov 7, 2025 |
| Mar 14, 2025 | CHRN EKSO BIONICS HOLDINGS, INC. | AGrant or award Common Stockindirect: By 401(k) | +5,590 | - | - | 5,590 | Mar 18, 2025 |
Questions about Scott G. Davis
Answered from the filings on this page, as of the latest one.
Is Scott G. Davis buying or selling?
In the last 12 months Scott G. Davis reported 0 open-market buys worth $0 and 1 open-market sell worth $112k on SEC Form 4; the latest was sold $112k of CHRN on Nov 10, 2025. Grants, option exercises and tax withholding are not counted.
How did Scott G. Davis's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Scott G. Davis has 0.
Where does Scott G. Davis file Form 4?
Scott G. Davis has filed Form 4 at CHRN (EKSO BIONICS HOLDINGS, INC.) as CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.